Quaker Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$240 Hold
4
– – ﹤0.01% 840
2026
Q2
$229 Sell
4
-4
-50% -$219 ﹤0.01% 868
2026
Q1
$452 Buy
8
+6
+300% +$350 ﹤0.01% 718
2025
Q4
$119 Buy
+2
New +$109 ﹤0.01% 916

Other funds holding BMRN

Quaker Wealth Management's BMRN Position: Q3 2026 in Review

Quaker Wealth Management held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 4 shares worth $240. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Quaker Wealth Management first reported a position in BMRN in Q4 2025 and has held it in 4 quarters since. The position peaked at $452 in Q1 2026. 559 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Quaker Wealth Management held 4 shares of BioMarin Pharmaceuticals worth $240 as of Q3 2026.
  • Quaker Wealth Management left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #840 holding.
  • Quaker Wealth Management first reported a position in BioMarin Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Quaker Wealth Management's BioMarin Pharmaceuticals position peaked at $452 in Q1 2026.
  • 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.